TY - JOUR
T1 - Pulmonary rehabilitation, physical activity, respiratory failure and palliative respiratory care
AU - Spruit, Martijn A.
AU - Rochester, Carolyn L.
AU - Pitta, Fabio
AU - Kenn, Klaus
AU - Schols, Annemie M. W. J.
AU - Hart, Nicholas
AU - Wouters, Emiel F. M.
AU - Nava, Stefano
AU - Dreher, Michael
AU - Janssen, Daisy J. A.
AU - Johnson, Miriam J.
AU - Curtis, Randall J.
AU - Sastry, Manuel
AU - Franssen, Frits M. E.
N1 - Funding Information:
Competing interests JRC, MD, MJJ, KK, SN, FP, MS, CLR, AMWJS and MAS have nothing to disclose. MD reports personal fees from Philips, ResMed, Weinmann, Heinen und Löwenstein, Fisher and grants from ResMed, outside the submitted work. FMEF reports personal fees from AstraZeneca, Chiesi, GlaxoSmithKline, Boehringer Ingelheim, Novartis and TEVA, outside the submitted work. NH is on the Pulmonary Research Advisory Board for Philips. NH’s research group has received unrestricted grants (managed by Guy’s) and Philips-Respironics is contributing to the development of the MYOTRACE technology. DJAJ reports personal fees from AstraZeneca, Novartis, Boehringer Ingelheim, GlaxoSmithKline and Mayne Pharma, outside the submitted work.
Publisher Copyright:
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.
PY - 2019/7
Y1 - 2019/7
N2 - The CIRO Academy in Horn (the Netherlands) organised a 2-day meeting to present and discuss the studies published in 2017 pertaining to key priority areas of respiratory and critical care medicine. This review summarises studies focussing on pulmonary rehabilitation and exercise training, physical activity, chronic respiratory failure and palliative respiratory care published in 2017.
AB - The CIRO Academy in Horn (the Netherlands) organised a 2-day meeting to present and discuss the studies published in 2017 pertaining to key priority areas of respiratory and critical care medicine. This review summarises studies focussing on pulmonary rehabilitation and exercise training, physical activity, chronic respiratory failure and palliative respiratory care published in 2017.
KW - INTERSTITIAL LUNG-DISEASE
KW - QUALITY-OF-LIFE
KW - POSITIVE-PRESSURE VENTILATION
KW - STABLE HYPERCAPNIC COPD
KW - NEEDS-ASSESSMENT TOOL
KW - NONINVASIVE VENTILATION
KW - OXYGEN-THERAPY
KW - SUPPLEMENTAL OXYGEN
KW - SEDENTARY BEHAVIOR
KW - RANDOMIZED-TRIAL
U2 - 10.1136/thoraxjnl-2018-212044
DO - 10.1136/thoraxjnl-2018-212044
M3 - (Systematic) Review article
C2 - 30872364
SN - 0040-6376
VL - 74
SP - 693
EP - 699
JO - Thorax
JF - Thorax
IS - 7
ER -